Article Information
History
- November 24, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anthony English1,2,3,
- Fleur Uittenbogaard1,2,3,
- Alexa Torrens4,
- Dennis Sarroza1,
- Anna Slaven1,2,
- Danielle Piomelli4,
- Michael Bruchas1,2,3,4,
- Nephi Stella1,2,3,6,* and
- Benjamin Land1,2,3
- 1Departments of Pharmacology, University of Washington, Seattle WA 98195
- 2UW Center of Excellence in Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle WA 98195
- 3Center for Cannabis Research, University of Washington, Seattle WA 98195
- 4Department of Anatomy & Neurobiology, University of California Irvine, Irvine CA
- 5Department of Anesthesiology, University of Washington, Seattle WA 98195
- 6Psychiatry & Behavioral Sciences, University of Washington, Seattle WA 98195
- ↵*Corresponding author; email: nsetlla{at}uw.edu
Posted November 24, 2022.
A preclinical model of THC edibles that produces high-dose cannabimimetic responses
